Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
flecainide potassium voltage-gated channel subfamily h member 2 small molecule NA drugbank Cardiac Arrhythmia[MeSHID:D001145]
Heart Ventricle[MeSHID:D006352]
Atrial Fibrillation[MeSHID:D001281]
Tachyarrhythmia[MeSHID:D013610]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,withdrawn inhibitor
flecainide e3 ubiquitin-protein ligase cop1 NA Successful target TTD Cardiac Arrhythmia[MeSHID:D001145]
Heart Ventricle[MeSHID:D006352]
Atrial Fibrillation[MeSHID:D001281]
Tachyarrhythmia[MeSHID:D013610]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved unknown
flecainide ryanodine receptor 2 small molecule NA drugbank Cardiac Arrhythmia[MeSHID:D001145]
Heart Ventricle[MeSHID:D006352]
Atrial Fibrillation[MeSHID:D001281]
Tachyarrhythmia[MeSHID:D013610]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,withdrawn inhibitor
flecainide voltage-gated sodium channel alpha nav1.9 NA Successful target TTD , DGIDB Cardiac Arrhythmia[MeSHID:D001145]
Heart Ventricle[MeSHID:D006352]
Atrial Fibrillation[MeSHID:D001281]
Tachyarrhythmia[MeSHID:D013610]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.15 approved unknown
flecainide sodium channel protein type 4 subunit alpha small molecule NA drugbank Cardiac Arrhythmia[MeSHID:D001145]
Heart Ventricle[MeSHID:D006352]
Atrial Fibrillation[MeSHID:D001281]
Tachyarrhythmia[MeSHID:D013610]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,withdrawn inhibitor
flecainide sodium channel protein type 5 subunit alpha small molecule NA drugbank , DGIDB Cardiac Arrhythmia[MeSHID:D001145]
Heart Ventricle[MeSHID:D006352]
Atrial Fibrillation[MeSHID:D001281]
Tachyarrhythmia[MeSHID:D013610]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.23 approved,withdrawn inhibitor
click here to return to the previous page